Sandoz Group (OTCMKTS:SDZNY) Sees Strong Trading Volume – Time to Buy?

Posted by Francis Steltz on Aug 5th, 2026

Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) saw strong trading volume on Wednesday . 47,894 shares traded hands during mid-day trading, an increase of 55% from the previous session’s volume of 30,840 shares.The stock last traded at $85.18 and had previously closed at $79.32.

Analysts Set New Price Targets

Separately, Barclays raised shares of Sandoz Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Strong Buy”.

View Our Latest Stock Report on Sandoz Group

Sandoz Group Price Performance

The firm has a fifty day moving average of $83.42 and a two-hundred day moving average of $82.46. The company has a current ratio of 1.18, a quick ratio of 0.77 and a debt-to-equity ratio of 0.53.

About Sandoz Group

(Get Free Report)

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.